Board Meetings for GLAXO
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 29 Oct 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2024 and dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 02 Aug 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 02 Aug 2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . | Board Meeting Intimation | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 17 May 2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. | Board Meeting Intimation | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 17 May 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 12 Feb 2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 12 Feb 2024 | Financial Results | To consider and approve the financial results for the period ended December 31, 2023 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 09 Nov 2023 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 . | Board Meeting Intimation | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 09 Nov 2023 | Financial Results | To consider and approve the financial results for the period ended September 30, 2023 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 26 Jul 2023 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 26-Jul-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . | Board Meeting Intimation | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 26 Jul 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 17 May 2023 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2023 to consider financial statements for the period ended March 2023, Financial results/Dividend. | Board Meeting Intimation | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 17 May 2023 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 07 Feb 2023 | Financial Results | To consider and approve the financial results for the period ended December 31, 2022 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 11 Nov 2022 | Financial results | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider financial statements for the period ended September 2022 |